Speech-Language Pathologists in Lima, OH Accepting Medicare

33 Speech-Language Pathologists found. Showing 1 - 20

Sara E Harris, MA. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2650 W Market St Apt 305b, Lima, OH 45805 Phone: 567-204-2647

Audrey Stachler Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 370 N Eastown Rd, Lima, OH 45807 Phone: 419-221-6051

Megan Fay Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3295 Bonnieview Dr, Lima, OH 45801 Phone: 419-303-8414

Mrs. Kara Amber Hartman, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 755 Saint Johns Ave, Lima, OH 45804 Phone: 419-996-3190

Celeste Hoverman, M.ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 816 College Ave, Lima, OH 45805 Phone: 419-996-3390    Fax: 419-996-3391

Mrs. Cheryl German, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1920 Slabtown Rd, Lima, OH 45801 Phone: 419-222-1836

Courtney Marie Kirk Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1920 Slabtown Rd, Lima, OH 45801 Phone: 419-222-1836

Trevor Scott Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1100 Shawnee Rd, Lima, OH 45805 Phone: 419-999-2010    Fax: 419-999-6284

Emily Looser Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1135 N West St, Lima, OH 45801 Phone: 419-996-3407

Kimberly Beach Stolly, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 804 S Mumaugh Rd, Lima, OH 45804 Phone: 419-225-9040

Mrs. Erin Butler, MS CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2651 Fort Amanda Rd, Lima, OH 45804 Phone: 419-228-8412    Fax: 419-999-6284

Alicia Moor Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 615 Tremont Ave, Lima, OH 45801 Phone: 419-996-3355

Emilie Ann Bialecki, M.A., CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1100 Shawnee Rd, Lima, OH 45805 Phone: 419-999-2010    Fax: 419-999-6284

Sandy Marshall, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 925 E 3rd St, Lima, OH 45804 Phone: 419-996-3643

Joleen Dillon, SPEECH/LANGUAGE PATH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1920 Slabtown Rd, Lima, OH 45801 Phone: 419-222-1836

Mrs. Angela Brown Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1920 Slabtown Rd, Lima, OH 45801 Phone: 419-222-1836

Miss Tara Zerbe Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 804 S Mumaugh Rd, Lima, OH 45804 Phone: 419-255-9561

Mrs. Betty Ann Smith Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1920 Slabtown Rd, Lima, OH 45801 Phone: 419-222-1836    Fax: 419-224-1010

Emily Ebbeskotte Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1100 Shawnee Rd, Lima, OH 45805 Phone: 419-999-2010    Fax: 419-999-6284

Caitlin Wurst Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1100 Shawnee Rd, Lima, OH 45805 Phone: 419-999-6284    Fax: 419-999-6284

News Archive

ARIAD Pharmaceuticals initiates ponatinib Phase 2 trial in adult patients with metastatic GIST

ARIAD Pharmaceuticals, Inc. today announced the initiation of the Phase 2 trial of Iclusig (ponatinib) in adult patients with metastatic and/or unresectable gastrointestinal stromal tumors.

Cyclophosphamide drug can eliminate life-threatening immune response after bone marrow transplants

Johns Hopkins and other cancer researchers report that a very short course of a chemotherapy drug, called cyclophosphamide, not only can prevent a life-threatening immune response in some bone marrow transplant recipients, but also can eliminate such patients' need for the usual six months of immune suppression medicines commonly prescribed to prevent severe forms of this immune response.

Clinical trial data from Array BioPharma's binimetinib and encorafenib presented at ECC 2015

Clinical trial results from Array BioPharma's wholly-owned MEK inhibitor, binimetinib, and BRAF inhibitor, encorafenib, were presented this weekend at the European Society of Medical Oncology's annual European Cancer Conference (ECC). At the meeting, preliminary data were shared from both a Phase 2 combination trial of binimetinib and encorafenib in BRAF-mutant melanoma patients (LOGIC2) and a Phase 1b/2 combination trial of binimetinib and ribociclib (Novartis, LEE011), a CDK4/6 inhibitor in NRAS-mutant melanoma patients.

Hydroxychloroquine drug fails to reduce mild-moderate pain from primary hand osteoarthritis

The results of an interventional trial presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that use of the disease-modifying anti-rheumatic drug hydroxychloroquine for 24 weeks did not diminish mild-moderate pain from primary hand osteoarthritis (OA).

Read more Medical News

› Verified 9 days ago

• 1(current)
• 2